RecruitingNot ApplicableNCT07155057

Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of DED in Patients Undergoing Cataract Surgery

A Prospective, Single-Arm Study Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of Dry Eye Disease in Patients Undergoing Refractive Cataract Surgery

Sponsor

Vance Thompson Vision

Enrollment

60 participants

Start Date

Sep 3, 2025

Study Type

INTERVENTIONAL

Conditions

Dry Eye Disease (DED)

Summary

To review how patients report using a hyaluronate crosslinked canalicular gel placed before cataract surgery

Eligibility

Min Age: 22 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Cross-Linked Hyaluronate Gel Prefilled Syringe 30 MG/3ML for people with dry eye disease (ded). The study is currently recruiting participants at 1 location. People eligible for this study include aged 22 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICECross-Linked Hyaluronate Gel Prefilled Syringe 30 MG/3ML

Prospective, single-site, single-arm study enrolling 60 patients who have elected advanced IOL implantation at the time of cataract surgery and have a diagnosis of dry eye disease. The study will consist of 5 study visits, over a 3-5 month time period. Patients will receive bilateral lacrimal occlusion of crosslinked hyaluronate canalicular gel pre-operatively